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EFFICACY AND SAFETY OF SODIUM HYALURONATE IN 
THE TREATMENT OF OSTEOARTHRITIS OF THE 
CARPOMETACARPAL JOINT OF THE THUMB VERSUS 
CORTICOSTEROID 
P Bruehlmann, D Frey, B Salzmann, A Koch, BA Michel 
Department of Rheumatology and Institute of Physical Medicine, 
University Hospital, Zurich, Switzerland 
Aim of Study: To assess whether one intra-articular (i.a.) injec- 
tion of sodium hyaluronate (SH) 1.0% would reduce pain and im- 
prove function over 6 months in patients with rhizarthrosis com- 
pared to corticosteroid. 
Methods:  This pilot, randomised, masked-observer, controlled 
study involved patients with symptomatic osteoarthritis of the car- 
pometacarpal joint of thumb. Pain on rotatory movement was re- 
quired to be >30 mm on 100 mm Visual Analogue Scale (VAS). 
After an analgesic washout period, patients received a single i.a. 
injection of either SH 10 mg/1 ml (Ostenil ® mini, TRB Chemed- 
ica AG, Germany) or triamcinolone acetonide (TA) 10 mg/1 ml. 
Patients were observed over 6 months with visits at Day 7, 
Week 4, 12, 24. Paracetamol was available as rescue analgesia. 
Three dimensions of pain were assessed as efficacy parameters 
and measured on VAS: overall pain of thumb/on rotatory move- 
ment/on joint shifting. Other parameters included VAS pain on 
pinch (tip, key, palmar), physician's assessment of disease activ- 
ity (VAS)and Dreiser Algofunctional Index (0-30). 
Results:  69 patients (mean age 63 years, 53 women) were ran- 
domised; 62 completed the study. Seven failed to complete due to 
adverse events (2), short efficacy duration (2), lack of efficacy (1), 
lost to follow up (1) and consent withdrawal (1). The 69 patients 
(SH=34, TA=35) were analysed as ITT. Mean overall pain values 
in SH group decreased significantly from 42.7 mm at baseline be- 
fore injection to 22.9 mm at Week 24 (p<0.001) and in TA group 
from 45.2 mm to 26.2 mm (p<0.01). No significant intergroup dif- 
ference was found. 
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Similar results were found for pain on rotatory movement, pain on 
joint shifting, pain on pinch and disease activity. 
Mean VAS values (mm) 
SH TA 
Baseline Week 24 Basel ine Week 24 
Overall pain 42.7 ±20.5 22.9 ±19.8 45.2 ±19.2 26.2 ±22.3 
Pain on rotatory 
movement 55.4 ±16.7 28.3 ±19.4 55.5 ±15.2 31.6 ±27.8 
Pain on joint shifting 39.7 ±25.7 21.6 ±17.8 37.3 ±20.1 21.6 ±23.3 
Pain on tip pinch 45.1 ±19.3 25.0 ±16.5 39.7 ±21.6 26.0 ±21.4 
Pain on key pinch 37.6 ±24.8 19.9 ±18.3 39.5 ±25.1 24.4 ±22.3 
Pain on palmar pinch 50.5 ±20.4 23.0 ±17.9 45.8 ±23.0 29.1 ±26.0 
Disease activity 55.3 ±14.2 26.3 ±20.3 55.5 ±11.6 22.8 ±18.0 
SH group exhibited a mean baseline Dreiser Index of 10.6 vs 9.5 
in TA group (p=ns). It decreased in both groups to reach 7.8 in 
SH group vs 6.8 in TA group (p=ns). Two patients dropped out of 
the study because of adverse events in SH group (acute low back 
pain and tendopathy of right thumb). 
Conc lus ions :  A single injection of SH led to significant improve- 
ment in pain and function and was as effective as TA for treating 
rhizarthrosis. Sustained improvement was demonstrated in both 
groups at all time points over 6 months. 
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CHONDROITIN SULFATE MAY HAVE DIFFERENTIAL 
EFFECTS ON OA SYMPTOMS RELATED TO DEGREE OF 
RADIOGRAPHIC INVOLVEMENT 
DO Cleqq, DJ Reda, MM Hooper, RW Moskowitz, the GAIT 
Investigators 
School of Medicine, University of Utah, Salt Lake City, UT 
The Glucosamine/chondroitin Arthritis Intervention Trial (GAIT) 
was a randomized double-blind placebo- and celecoxib-controlled 
trial of 1583 OA patients designed to evaluate the efficacy 
of glucosamine (G), chondroitin sulfate (CS), and combination 
(G+CS) in improving osteoarthritis (OA) knee pain. GAIT patients 
had symptomatic and radiographic (Kellgren and Lawrence (KL) 
Grades 2 or 3) OA. We report a subanalysis of GAIT results 
based on interaction of KL Grade and CS response relative to 
placebo. 
As expected, baseline characteristics demonstrated that patients 
with KL3 radiographic disease were significantly older, more 
obese and had more severe OA in terms of disease duration, 
baseline WOMAC, patient global and quality-of-life measures. 
The following table details treatment outcomes by KL Grade. 
Interactions between treatment group and KL Grade are signif- 
Abstract P145 - Table 1 
Outcome Measure KL Chondroitin Sulfate n=318 Placebo n=313 P values 
KL Grade 2 vs 3 CS vs Placebo Treatment group by 
by KL Grade interaction 
Percent treatment responders 
Primary (WOMAC 20) 2 72.6% 63.1% 0.0016 0.1046 0.1668 
3 55.3% 56% 
OME RACT-OARSI 2 71.0% 59.8% 0.0015 0.0721 0.1345 
3 53% 53% 
Change in WOMAC Subscales 
Pain 2 -101.5 -90.3 0.0042 0.0907 0.0753 
3 -59.5 -80.4 
Stiffness 2 -40.7 -37 0.0049 0.0271 0.0120 
3 -18.1 -35.7 
Function 2 -289.6 -218.6 0.0617 0.0100 0.0101 
3 -160.3 -239.2 
Change in Swelling 2 10.6 16.7 0.0508 0.0138 
3 15.0 24.2 
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icant for WOMAC Stiffness and Function while WOMAC Pain 
shows a trend, indicating better response for CS relative to 
placebo for KL2 compared with KL3. Treatment responder analy- 
ses show trends for interaction, indicating potential advantage of 
CS over placebo for KL2 compared with no difference between 
CS and placebo for KL3. Joint swelling shows no interaction but 
a significant treatment difference, indicating an advantage of CS 
over placebo independent of KL Grade. In general, CS response 
within the KL 2 group is very similar to that seen for celecoxib, in 
contrast to the KL 3 group where the response was more similar 
to, and in some instances, worse than placebo. Similar variations 
related to KL grade were not seen for the G or G+CS groups. 
While little is known about potential biologic effects of dietary 
supplements, these results suggest that the extent of radio- 
logic disease may be an important factor in response in symp- 
tomatic OA. These results suggest that CS may improve OA 
knee pain in patients with relatively early radiographic dis- 
ease, a time when bone-related structural responses (osteo- 
phytes, subchondral sclerosis) are prominent and differential 
osteoblast cytokine/PGE2 interactions have been noted (Os- 
teoarthritis Cart,10:491-500, 2002;and 7:321-2, 1999). Similar 
differential structure-pain responses have been reported with in- 
traarticular hyaluronans (Clin Exp Rheumatol, 3:307-11, 2003). 
Additional research will help explain differential responses in the 
KL grade subgroups. 
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MEASUREMENT OF KNEE JOINT IMPACT DURING GAIT 
WITH THREE-DIMENSIONAL LINEAR ACCELERATIONS: 
REPRODUCIBILITY ON A MEDIAL KNEE 
OSTEOARTHRITIS POPULATION 
K Turcot 1 , R Aissaoui 1,2, M Pelletier 3, N Hagemeister 1,2, G 
Parent 1 , JA de Guise 1,2 
1Laboratoire de Recherche en Imagerie et Orthopedie, Centre 
de Recherche du CHUM, Hopital Notre-Dame, Montreal, QC, 
Canada; 2Genie de la Production Automatisee, Ecole de 
Technologie Superieure, Montreal, QC, Canada; 3 physiatrie, 
Hopital Notre-Dame, CHUM, Montreal, QC, Canada 
Aim: Many studies had shown the potential of accelerometric 
sensors to estimate the transmission of shock loading through 
the skeleton during functional activities. Knowing that knee os- 
teoarthritis is an important degenerative pathology affecting joint 
absorption, a method that estimate knee joint impact using three- 
dimensional (3D) linear accelerations was developed. Repro- 
ducibility of the proposed method is presented here on a knee 
osteoarthritis population. 
Methods: 20 subjects with medial knee osteoarthritis (confirmed 
by X-Rays) were included in this study (62.7 4- 7.4 years). Linear 
accelerations were estimated at both proximal-tibial and distal- 
femoral local coordinate segment origins. Biomechanical eval- 
uation consisted in a treadmill walking gait evaluation at self- 
determined speed. Data were collected during a 25 seconds trial. 
VlCON motion analysis system was used to track the position 
and the orientation of the lower limb segment in 3D space. Knee 
joint coordinate system was defined using a functional postural 
calibration method. Two triaxial gyroscopes and two triaxial ac- 
celerometers were fixed at the thigh and shank levels to mea- 
sure angular velocity and linear accelerations of each segment 
in medial lateral (ML), anterior posterior (AP) and proximal distal 
(PD) directions. Motion sensors, accelerometers and gyroscopes 
were all rigidly fixed on an exoskeleton to minimize skin-mounted 
sensor vibration. Data were collected at a frequency of 120 Hz. 
In order to establish the reproducibility of the measurement, all 
subjects participated in two evaluation sessions separated by 6 
to 8 days. Both evaluations were compared during heel contact 
and toe-off gait cycle phases instants. Altogether, 36 values were 
computed (maximum, minimum and range values of linear ac- 
celerations for each instant and each segment) and statistically 
compared with a Student t-test to insure that no significant differ- 
ence (p > 0.05) exist between measurement session. 
Results: Data showed good reproducibilitywith no significant dif- 
ference for 33 of the 36 values tested. However, a significant dif- 
ference was found for the maximal AP acceleration value of the 
femur at heel contact (p < 0.02) and on both the minimal PD lin- 
ear acceleration of the tibia (p < 0.03) and its range (p < 0.005) 
at the instant of toe-off. 
Conclusion: Linear accelerations found in this study showed 
consistent results between session evaluations. Hence, femoral 
and tibial linear accelerations will be useful to assess knee joint 
impact in a follow-up osteoarthritis population. Preliminary results 
from patients that have sustained a rehabilitation treatment in 
physiotherapy show a decrease in linear acceleration magnitude. 
These findings could indicate the capacity of patients to reduce 
their impact loading during walking gait after the rehabilitation 
treatment. 
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FUNCTIONAL ABILITIES OF PERSONS WITH AND 
WITHOUT KNEE OA IN ESTONIAN 34-54 YEAR 
POPULATION: ELVA STUDY 
AO Tamm 1 , AE Tamm 2, K Veske 3, Y Hansen 4 
1Laboratory Medicine, University of Tartu, Tartu, Estonia; 
2Sports Medicine and Rehabilitation, University of Tartu, Tartu, 
Estonia; 3Department of Radiology, Tartu University Clinics, 
Tartu, Estonia; 4 YH Family Practice, YH Family Practice, Elva, 
Tartu Coun~ Estonia 
Symptoms, signs, functional limitations and radiographic alter- 
ations are characteristic features of advanced knee OA in older 
population. There is a gap in our knowledge which are the first 
limitations of functional capacities in younger persons with early 
grades of knee OA (KOA). 
A im was to study functional abilities of persons with and without 
KOA in popu-lation aged 34-54 
Subjects: All 559 persons Of age 34-54 from one family doctor 
(FD) register got postal questionnaire. 220 out of 348 (64%) of 
responders noted pain or other symp-toms or functional limita- 
tions. 162 subjects out of 220 (101 F; 61 M; mean age 45 years) 
agreed to undergo in-depth examination voluntarily. 
Methods: Radiological KOA was diagnosed by weight-bearing 
AP radiographs tibio-femoral, TF, and prone radiographs for 
patello-femoral, PF, compartments. Subjects ability to use their 
knees was assessed by two new sub-scales of advanced 
WOMAC scale-KOOS (Roos, 1999) questionnaire: Activities of 
Daily Living (ADL) and Sport/Recreation (SP/REC) and (iii) by 
three functional tests-30 m maximal walking speed (30MWS) and 
stepping up test (SUT) separately with left/right leg and flexion- 
extension of the knees was measured using standard goniometry. 
Results: KOOS: Grade I OA (both in TF and PF joint) was accom- 
panied with decrease of score on Sport/Rec scale (p= 0.0006) 
in women but not in men. Women had also more pain (p=0.04), 
more limitations in ADL (p= 0.025) in case of grade I TF OA. In 
men grade II PF OA was associated with more symptoms (but no 
knee pain) comprised with grade 0 PF OA (p= 0.013) 
Tests: The women with TF I OA were less able to bend their 
knee compared with the women without OA (left rs = - 0.410, p = 
0.00001, right rs = - 0.239, p=0.02;). Women with PF II OA were 
less able to bend their knees than women without PF OA (p = 
0,01). In SUT with right leg women with PF I OA and TF I OA had 
lower results in comparison with women without OA (p=0,047 and 
p=0,002). Women with PF I OA and TF I OA had slower walking 
speed in comparison with women without PF or TF OA accord- 
ingly p = 0,019 and p = 0,04 in 30MWS. Women with higher BMI 
